Skip to Content
Søg Menu

Telepresence-robotter hjælper kræftsyge børn med at gå i skole

/ Mette Weibel / Hanne Bækgaard Larsen
BørnTeknologiCancer

EADV24: Semaglutide Shows Promising Outcomes for Obese Patients with Hidradenitis Suppurativa

/ Sofie Pohl
EADV24Hidradenitis Suppurativa

EADV24: BestPractice Nordic Covers the EADV Congress 2024

/ BestPractice Nordic
EADV24

ECTRIMS 2024: New Data Has the Potential to Paving the Way for More Personalised and Effective Treatment Plans

/ Jan Andreasen
ECTRIMS24MS

Earlier Access to Effective Treatments for Children with MS Reduces the Burden of Long-Term Disability

/ Jan Andreasen
ECTRIMS24MS

ESMO24: Immunotherapy Plus Chemotherapy Improves Progression-Free Survival in Metastatic Anal Cancer

/ Jan Andreasen
ESMO24Kolorektal cancer

ECTRIMS 2024: The World’s Largest MS Congress in Copenhagen 

/ BestPractice Nordic
ECTRIMS24MS

ESMO24: First-Line Immunotherapy Combination Improves Overall Survival in HER2-Positive Metastatic G/GEJ Adenocarcinoma

/ Jan Andreasen
ESMO24Esofaguscancer

ESMO24: New Standard of Care – Immunotherapy in High-Risk Locally Advanced Cervical Cancer

/ Jan Andreasen
ESMO24Gynækologisk cancer

New Data on Trastuzumab Deruxtecan Shows Promising Outcomes in HER2-Positive Metastatic Breast Cancer with Brain Metastases: Results from DESTINY-Breast12

/ Jan Andreasen
ESMO24Brystcancer
Back to top